A recent review study suggests that the development of certain antivirals and gene therapy are likely to progress quickest in the fight against dangerous coronviruses such as SARS-CoV-2
Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks, and buffy coats for COVID-19, cell, and gene therapy research within hours of collection
BioIVT’s acquisition of Clinical Trial Laboratory Services (CTLS) and its London donor center is enabling this rapid turnaround time for high quality blood-derived immune cells for cell and gene therapy research